Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Travatan

 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

travoprost
travoprost 0.04 MG/ML Ophthalmic Solution [Travatan]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Comparison of BAK free Travatan with BAK Preserved Xalatan in Terms of Ocular Surface Disease in Glaucoma patients in our population
Objective: To assess symptoms of ocular surface disease (OSD) in patients treated with a BAK-preserved Xalatan (Latanoprost) to… Expand
  • table 1
  • table 2
  • table 3
2011
2011
Polyoxyethylene hydrogenated castor oil modulates benzalkonium chloride toxicity: comparison of acute corneal barrier dysfunction induced by travoprost Z and travoprost.
PURPOSE To determine the element that modulates benzalkonium chloride (BAC) toxicity by using a new electrophysiological method… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2011
2011
Real-life experience study of the safety and efficacy of travoprost 0.004% / timoptol 0.50% fixed combination ophthalmic solution in intraocular pressure control.
PURPOSE To evaluate the safety and efficacy of timolol 0.5%/travoprost 0.004% combination (duotrav) as observed in primary open… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
2011
2011
Treatment persistency of Xalatan-Xalacom, Lumigan-Ganfort and Travatan-Duotrav: An analysis conducted on the United-Kingdom General Practitioner Research Database
 
2010
2010
Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN or TRAVATAN.
PURPOSE To quantify the aqueous humor (AH) concentrations of bimatoprost (amide), travoprost (isopropyl ester), and their… Expand
2010
2010
Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells
Purpose The toxicity of antiglaucoma medications to ocular surface cells has been evaluated extensively; however, the toxicity to… Expand
  • table 1
  • figure 1
  • figure 2
2010
2010
Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines
Purpose: This study evaluated the cytotoxicity of five prostaglandin analog ophthalmic solutions on four ocular surface cell… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
2007
2007
Travoprost Z ophthalmic solution with sofZia: clinical safety and efficacy
Travoprost Z (Travatan® Z) ophthalmic solution has recently been approved for the reduction of elevated intraocular pressure (IOP… Expand
2006
2006
Влияние траватана на внутриглазное давление у больных с первичной открытоугольной глаукомой различных стадий
The aim of investigation was to study the effect of travatan on intraocular pressure (IOP) in patients with primary open-angle… Expand
2006
2006
Опыт работы школы «Глаукомного больного». В г. Перми
The aim of investigation was to study the effect of travatan on intraocular pressure (IOP) in patients with primary open-angle… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE